Exane Derivatives Personalis, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
Shares
4 transactions
Others Institutions Holding PSNL
# of Institutions
91Shares Held
30.1MCall Options Held
27.5KPut Options Held
85.4K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.09MShares$24.5 Million0.36% of portfolio
-
Aigh Capital Management LLC Baltimore, MD4MShares$13.8 Million8.7% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$11.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.44MShares$8.43 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$6.82 Million0.0% of portfolio
About Personalis, Inc.
- Ticker PSNL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 45,918,400
- Market Cap $159M
- Description
- Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...